Pascal Claudepierre

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

The DESIR cohort: A 10-year follow-up of early inflammatory back pain in France: Study design and baseline characteristics of the 708 recruited patients

Maxime Dougados, Maria Antonietta D’Agostino, Joëlle Bénessiano et al. · Joint Bone Spine · 2011 · 225 citations

Pain Therapy, Health Sciences, Pain Medicine +10

Effectiveness, Safety, and Predictors of Good Clinical Response in 1250 Patients Treated with Adalimumab for Active Ankylosing Spondylitis

Martín Rudwaleit, Pascal Claudepierre, P Wordsworth et al. · The Journal of Rheumatology · 2009 · 217 citations

Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug

Jacques-Eric Gottenberg, Olivier Brocq, Aleth Perdriger et al. · JAMA · 2016 · 185 citations · Full text

Differences Between Women and Men With Recent‐Onset Axial Spondyloarthritis: Results From a Prospective Multicenter French Cohort

Anne Tournadre, Bruno Pereira, A. Lhoste et al. · Arthritis Care & Research · 2013 · 174 citations